Stockwinners Market Radar for April 20, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

CE

Hot Stocks

18:02 EDT Celanese announces price increases in Asia - Celanese will increase list and off-list selling prices for acetyl intermediate products, raising Acetic Acid price by $100 per ton and Acetic Anhydride by $125 per ton. The price increases below will be effective immediately or as contracts otherwise allow, and are incremental to any previously announced increases.
IOTS

Hot Stocks

17:33 EDT 180 Degree Capital lowers stake in Adesto Technologies to 5.8% from 7.3%
SIGM

Hot Stocks

17:22 EDT Sigma Designs to delay filing Annual Report on Form 10-K - Sigma Designs is unable to file its annual report on Form 10-K for the fiscal year ended February 3, 2018 within the prescribed period due to the recently completed sale of its assets related to the Company's Z-Wave business, which transaction was completed on April 18, 2018. The process of compiling and reporting the information required to be included in the Form 10-K, as well as the completion of the required review of its financial information, could not be completed by the filing deadline without incurring undue hardship and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, the registrant will file the Annual Report no later than the fifteenth calendar day following the prescribed due date.
BRK.A...

Hot Stocks

17:22 EDT Berkshire Hathaway reports 5.6% passive stake in Torchmark
AVAV

Hot Stocks

17:12 EDT AeroVironment awarded $44.7M U.S. Army contract modification - AeroVironment was awarded a $44,691,196 modification to contract W31P4Q-17-C-0193 for hardware and parts for Block 10C inert training vehicles, Block 10C all up rounds, multi pack launchers, and modular battery payloads. Work will be performed in Simi Valley, California, with an estimated completion date of Sept. 19, 2019.
WMT FB

Hot Stocks

17:05 EDT Walmart says Kevin Systrom will not stand for re-election to board - Walmart and Systrom, the co-founder and CEO of Instagram, mutually agreed he would not stand for re-election as he prioritizes work, board responsibilities and other outside commitments. Systrom joined the Board in 2014 and served as chair of the Technology and eCommerce Committee and was a member of the Compensation and Management Development Committee.
WMT MCD

Hot Stocks

17:03 EDT Walmart announces McDonald's Steve Easterbrook as independent nominee to board - "This year's Proxy materials seek shareholders' votes on 11 director nominees, two company proposals and two shareholder proposals. Dr. James Cash is retiring from the Board, and Kevin Systrom will not stand for re-election. As Walmart maintains its commitment to an independent Board, it announced Steve Easterbrook, CEO of McDonald's, as a new independent nominee."
GIFI

Hot Stocks

16:51 EDT PVAM Perlus Microcap Fund reports 5.3% passive stake in Gulf Island Fabrication
HNI

Hot Stocks

16:39 EDT HNI Corporation CEO says 'seeing increased inflationary pressures' - "We continue to project solid top line growth and strong productivity improvement in 2018. We are seeing increased inflationary pressures. While we are working to offset these cost increases, they will have a negative impact on our results, particularly in the second quarter. We continue to be excited about our competitive position and expect to deliver solid profit improvement for the year," said CEO Askren.
ARA

Hot Stocks

16:33 EDT American Renal Associates announces preliminary settlement of litigation - American Renal Associates announced that the company has received preliminary approval of the settlement of a stockholder derivative action brought by Plaintiff Stephen Bushansky, and pending in the United States District Court for the District of Massachusetts. The proposed settlement releases all claims asserted against the company and the other named defendants in the Bushansky Action without any liability or wrongdoing attributed to them. The proposed settlement remains subject to court approval and other customary conditions.
SONA

Hot Stocks

16:33 EDT Southern National Bancorp appoints Jeffrey Culver COO - Southern National Bancorp of Virginia announced that Jeffrey Culver has been appointed president and COO of Southern National, effective May 7. Culver most recently served as executive VP and COO of Access National Bank.
HNI

Hot Stocks

16:32 EDT HNI Corporation CEO Stan Askren to retire, Jeffrey Lorenger to succeed - HNI Corporation announced the retirement of Stan Askren and the promotion of Jeffrey Lorenger as President, HNI Corporation and the election of Lorenger to the Board of Directors of HNI Corporation. Askren informed the Board he expects to retire as CEO and Chairman of the Board of Directors no later than December 31, 2018. The Board anticipates Lorenger will be promoted to CEO before the end of the year. Askren' s announced retirement along with Lorenger's promotion to President of HNI Corporation and election as a Director are part of a long-planned and orderly succession process that has been underway for an extended period. Lorenger joined HNI Corporation in 1998 and has held multiple executive level positions including as President, Office Furniture; President, Contract Furniture Group; President, Allsteel; Vice President, Sales and Marketing, The HON Company; and Vice President, General Counsel and Secretary for HNI Corporation.
PVAC

Hot Stocks

16:32 EDT Encompass Capital Advisors reports 5.4% passive stake in Penn Virginia
PRK

Hot Stocks

16:17 EDT Park National raises quarterly dividend to 96c per share from 94c - Park National's board of directors increased the quarterly cash dividend from 94c per common share to 96c per common share. The board also approved a special one-time cash dividend payment of 25c per common share. Both dividends are payable on June 8, 2018 to common shareholders of record as of May 18, 2018. Park last increased its dividend more than ten years ago, and had maintained a consistent dividend throughout the great recession.
TRMB

Hot Stocks

16:16 EDT Trimble acquires assets of FabSuite, terms not disclosed - Trimble announced that it has acquired the assets of Williamsburg, Virginia-based FabSuite, a North American supplier of Management Information System solutions for steel fabrication. With the acquisition of FabSuite software, Trimble's portfolio now includes the complete structural steel workflow for planning, managing, designing, modeling and automating the fabrication processes to maximize constructability. Financial terms were not disclosed.
CE

Hot Stocks

16:15 EDT Celanese names Benita Casey chief accounting officer - Celanese Corporation announced the appointment of Benita M. Casey as chief accounting officer. Casey assumes this role from Kevin Oliver, who, in addition to his chief accounting officer role, successfully served as interim chief financial officer until Scott Richardson's appointment in February. As part of the company's commitment to developing employees, Oliver is relocating to assume the role of CFO of Celanese's European headquarters in Amsterdam. Casey joined the company in January as vice president, finance and controller. In her expanded role, she will add global responsibility for SEC reporting, internal reporting, accounting, and Sarbanes-Oxley compliance.
SSW

Hot Stocks

16:15 EDT Seaspan COO/General Counsel Mark Chu steps down - Seaspan Corporation announced that Mark Chu has notified the company that he plans to step down from his roles as General Counsel and Chief Operating Officer to pursue other opportunities. Mr. Chu will remain in his current roles through August 31st, 2018 to help facilitate a seamless transition.
ULTI

Hot Stocks

15:51 EDT Ultimate Software announces SMS Equipment to use its reporting product - Ultimate Software announced that SMS Equipment, a one-stop supplier of a broad range of equipment, production attachments, as well as parts and service, is using UltiPro's reporting functionality to transform the roles and responsibilities of the Payroll department. With locations across Canada, SMS Equipment, the largest dealer of Komatsu equipment in North America, serves customers in various industries including construction, forestry, mining, and road & mineral. Prior to UltiPro, the company was experiencing poor access to payroll data and analytics, and a lack of direct control over its payroll process. In addition, the company's HR system relied heavily on spreadsheets, and there was no consistent process for HCM across the company's 40 locations. SMS Equipment chose UltiPro to serve its needs as a growing company with over 2,000 employees, and went live in November 2013.
ALXN

Hot Stocks

15:36 EDT Alexion says no licence of Soliris was requested or granted in Brazil - Recent media reports have incorrectly stated that the Brazilian Superior Court of Justice has granted a compulsory license of Soliris. Alexion would like to clarify that no compulsory license of Soliris was requested or granted in Brazil. The recent decision by the court refers to a different legal matter with the Brazilian Patent Office related to a Soliris mailbox patent that expired in 2015. Alexion is evaluating the full decision by the court in this patent case before exploring the options to respond. Alexion continues to have patent applications pending in Brazil that would provide additional protection to Soliris. Brazil represents a low single digit percentage of Alexion's worldwide sales. This patent matter has no implications for intellectual property outside of Brazil.
VIA...

Hot Stocks

15:29 EDT Box Office Battle: 'A Quiet Place' expected to creep back into top spot - Expected to return to the top spot in its third weekend at theaters is Viacom (VIA, VIAB) subsidiary Paramount's horror film "A Quiet Place," which is expected to earn an additional $21M domestically at over 3,800 theaters. Expected to drop into second is last weekend's winner, Time Warner (TWX) subsidiary Warner Bros' "Rampage," based on the classic arcade game of the same name, and starring Dwayne Johnson alongside giant CGI animals-turned-monsters. "Rampage" is expected to earn around $17M in its second weekend at theaters. Rounding out the top three is expected to be STX's release of Amy Schumer's "I Feel Pretty," which is expected to open in the $13M-$15M range after a mixed early response to the comedy. Comcast (CMCSA, CMCSK) subsidiary Universal and Blumhouse's thriller "Truth or Dare" is expected to earn an additional $7M-$8M in its second weekend at theaters. In its fourth weekend at theaters, Warner Bros. sci-fi action flick "Ready Player One," directed by Steven Spielberg, is expected to earn an additional $7M, taking the domestic total of the film over $125M. Other publicly traded companies in filmmaking include 21st Century Fox (FOX, FOXA), Disney (DIS), Lionsgate (LGF.A, LGF.B), and Sony (SNE).
MEOH

Hot Stocks

15:25 EDT M&G Investment Management lowers stake in Methanex to 15.9% from 20.8%
OPBK

Hot Stocks

15:16 EDT SCW Capital reports 5.5% passive stake in OP Bancorp
VALU

Hot Stocks

15:08 EDT Value Line raises quarterly dividend 5.56% to 19c per common share - Value Line announced that its board of directors declared on April 20, 2018 a quarterly cash dividend of 19c per common share, payable on May 10, 2018, to stockholders of record on April 30, 2018. The company has 9,691,620 shares of common stock outstanding as of April 20, 2018.
LLY

Hot Stocks

14:53 EDT Eli Lilly says Phase 3 RANGE study didn't reach statistical significance for OS - Eli Lilly announced additional results from its global, randomized, double-blind, placebo-controlled Phase 3 RANGE trial evaluating CYRAMZA in combination with docetaxel in patients with locally advanced or unresectable or metastatic urothelial carcinoma whose disease progressed on or after platinum-based chemotherapy. A positive trend was seen in the secondary endpoint of overall survival, or OS, which did not reach statistical significance. An improvement in objective response rate was observed. Lilly previously announced that the trial met its primary endpoint of investigator-assessed progression-free survival; those results were presented at the European Society for Medical Oncology 2017 Congress and simultaneously published in The Lancet. Levi Garraway, M.D., Ph.D., senior vice president, global development and medical affairs, Lilly Oncology, said, "Although this study didn't reach statistical significance for overall survival, we are encouraged by the totality of the RANGE results and look forward to reviewing the data with internal and external experts to determine next steps." Lilly said it remains committed to the investigation and use of CYRAMZA in other tumor types, including those in which it has already demonstrated a Phase 3 overall survival benefit - stomach, non-small cell lung, colorectal and liver cancer.
WEN

Hot Stocks

14:02 EDT Wendy's announces 2020 goal of opening over 600 new restaurants globally - The Wendy's Company has announced a 2020 goal of opening more than 600 new restaurants across the globe. As part of its efforts to grow and differentiate the brand while keeping energy stewardship at the forefront, Wendy's recently unveiled a new "Smart Family of Designs," providing a portfolio of development options to franchisees, including buildings that fit into smaller footprints. These designs provide more access to real estate, the ability to customize needs for specific trade areas and reduces the development investment for franchisees looking to build new restaurants. Wendy's recently introduced the Smart 2.0 design, which reduces environmental impact with an even smaller footprint and features that promote energy efficiency, while targeting an additional $150,000 of savings in development costs. This next generation of Wendy's Smart designs, which were first introduced in 2017, complements the company's commitment to reduce the amount of energy used in company-owned and operated restaurants by 20% by 2025, as part of its participation in the Department of Energy's Better Buildings Challenge.
ALXN

Hot Stocks

13:46 EDT Alexion drops after Brazil AG says Soliris patent made public - Shares of Alexion Pharmaceuticals (ALXN) have dropped after the Attorney General of the Union of Brazil announced that the Federal Attorney General's Office won a unanimous decision in the Third Panel of the Superior Court of Justice that makes public the patent on Alexion's Soliris. Currently, Soliris is not sold in pharmacies, and is only available through the Unified Health System in Brazil, according to a translation of the Attorney General's announcement. In the STJ, the AGU argued that patents on drugs and chemicals registered between January 1995 and May 1996 have already expired, which makes generic competition possible. In the translation of the announcement, the AG said that Soliris, also known as eculizumab, is "one of the most expensive remedies in the world and the only one available to treat disease rare that affects the blood system. Success paves the way for generic drug production at a much more affordable price." In afternoon trading following the news, Alexion shares have fallen $8.87, or 7.9%, to $102.87. Reference Link
WAB GE

Hot Stocks

13:18 EDT Wabtec rises after report of talks for GE rail business deal - Shares of Wabtec (WAB) have risen to their session highs after Bloomberg reported that the company is in talks to potentially buy General Electric's (GE) locomotive business. GE is considering a deal to combine its rail business with Wabtec, according to Bloomberg, citing people familiar with the matter. Following the report, Wabtec shares are up about 3%.
SBGI...

Hot Stocks

13:10 EDT Sinclair drops with judges reportedly skeptical of FCC in deal case - Shares of Sinclair Broadcast (SBGI) are moving lower after Bloomberg reported earlier that judges at the U.S. Court of Appeals for the D.C. Circuit are skeptical of the Federal Communications Commission's stance on the company's proposed acquisition of Tribune Media (TRCO). Shares of Sinclair are down 5% to $28.98 while Tribune is down 4% to $39.17 in afternoon trading. Federal judges questioned why the FCC had reinstated a rule allowing owners of some TV stations to count just part of their audience when tallying holdings against a national limit of 39%, according to Bloomberg. The issue is a key factor to Sinclair's proposed purchase of Tribune, which would leave it covering 72% of U.S. households, or about 45% when counting half the audience as allowed under the embattled rule, Bloomberg notes. Other media stocks are declining today, including CBS (CBS), Gray Television (GTN) and Tegna (TGNA) and Media General (MEG). Reference Link
BHGE

Hot Stocks

13:04 EDT Baker Hughes reports U.S. rig count up 5 to 1,013 - Baker Hughes reports that the U.S. rig count is up 5 rigs from last week to 1,013, with oil rigs up 5 to 820, gas rigs unchanged at 192, and miscellaneous rigs unchanged at 1. U.S. Rig Count is up 156 rigs from last year's count of 857, with oil rigs up 132, gas rigs up 25, and miscellaneous rigs down 1 to 1. The U.S. Offshore Rig Count is up 2 rigs to 18 and down 2 rigs from last year's count of 20. The Canada Rig Count is down 9 rigs from last week to 93, with oil rigs down 3 to 38 and gas rigs down 6 to 55. The Canada Rig Count is down 6 rigs from last year's count of 99, with oil rigs up 5 and gas rigs down 11.
BG ADM

Hot Stocks

12:51 EDT Bunge, Archer Daniels fall after Bloomberg says talks end with no deal - The advanced stage merger talks between Bunge (BG) and Archer Daniels Midland (ADM) have ended without an agreement, Mario Parker and Javier Blas of Bloomberg report, citing people familiar with the matter. ADM could not overcome potential antitrust issues, sources told Bloomberg. Shares of Archer Daniels Midland are down 51c to $45.28 following the report while Bunge is down $1.80 to $73.90.
IONS BIIB

Hot Stocks

12:51 EDT Ionis CEO says takeover by Biogen previously discussed - Ionis Pharmaceuticals CEO Stanley Crooke said on CNBC that a takeover by Biogen (BIIB) was discussed in the past. The companies this morning announced an expanded partnership.
ALNY DRNA

Hot Stocks

12:51 EDT Alnylam confirms settlement agreement with Dicerna, will get $25M payment - Alnylam Pharmaceuticals (ALNY) announced that it has entered into a settlement agreement with Dicerna Pharmaceuticals (DRNA) resolving trade secret misappropriation claims against Dicerna, and counterclaims asserted by Dicerna, in pending litigation in the Superior Court of Middlesex County, Massachusetts. The settlement also resolves claims asserted by Dicerna in a lawsuit against Alnylam in the United States District Court for the District of Massachusetts. Each party has agreed to dismiss all pending litigation between the companies, with prejudice. Under the terms of the agreement, Dicerna will pay $25M comprised of cash and stock to Alnylam, and Dicerna will be restricted in its development and other activities relating to oligonucleotide-based therapeutics directed toward a defined set of Alnylam targets, for periods ranging from 18 months up to four years. The settlement does not include any license to Alnylam's GalNAc conjugate intellectual property or any licenses to any other IP from either party. Nor does the settlement include any admission of liability or wrongdoing by either company. All other settlement terms are confidential.
ATVI...

Hot Stocks

12:37 EDT 'Big 3' video game makers in focus as Piper sees E3 catalyst - Shares of the "big three" U.S. video game publishers, namely Activision Blizzard (ATVI), Electronic Arts (EA), and Take-Two (TTWO), were in focus after an analyst from Piper Jaffray said that this year's Electronic Entertainment Expo, or E3, could prove more of a catalyst this year than in prior years. The analyst noted that video game stocks typically outperform the broader market in the 60 days leading up to E3. PIPER SEES STRENGTH HEADING INTO E3: In a research note to investors, Piper Jaffray analyst Michael J. Olson said that, in the midst of "Fortnite" fears reaching a fever pitch, it was worth looking back at how game stocks typically perform ahead of E3, which is scheduled for June 12-14 in Los Angeles, California. The analyst highlighted that this has historically been a time that the group consistently outperforms the broader market, noting that the main three publishers have an average 5-year move of up 15% in the 60 days heading into E3. Olson added that this year's E3 could prove more of a catalyst than previous years due to a high likelihood of announcement and discussion of so-called battle royale modes being added to major titles later this year, which will help fend off some of the real and perceived risk of share loss to Epic Games' "Fortnite." The analyst said he would "not be surprised" to see battle royale modes added to EA's "Battlefield" and "Star Wars Battlefront II," Activision's "Call of Duty," and Take-Two's "Red Dead Redemption 2." He noted that while not all of these additions would be announced at E3, he expects a mix of announcements and "chatter" on the subject of battle royale efforts. Olson reiterated Overweight ratings on Activision Blizzard, EA, and Take-Two. PREVIOUS PIPER NOTE: Today's Piper note reaffirms a similar sentiment from the same analyst a month ago, when Olson said bigger publishers will catch up quickly to the battle royale trend made famous by "Fortnite" and "PlayerUnknown's Battlegrounds," whose mobile version is published by Tencent (TCEHY) and console version is published by Microsoft (MSFT). Olson said at the time that "Fortnite" and "PUBG" may have had some short-term impact on time/wallet share for big publishers, but that he expected this impact to be temporary as these publishers incorporate similar battle royale modes into existing titles. WHAT'S NOTABLE: Earlier this week, Kotaku reported that Activision's upcoming shooter "Call of Duty: Black Ops 4" will be multiplayer-only and feature a battle royale mode. PRICE ACTION: In afternoon trading, Activision Blizzard and EA fell 2%, and Take-Two slipped about 3.1%.
DRNA ALNY

Hot Stocks

12:16 EDT Dicerna settles litigation with Alnylam for $15M plus 983,208 shares - Dicerna Pharmaceuticals (DRNA) announced that the company has resolved all litigation with Alnylam Pharmaceuticals (ALNY). "The settlement allows Dicerna to advance all of its key and planned pipeline programs while maintaining a strong balance sheet," the company said in a statement. Under terms of the agreement, Alnylam will dismiss all claims of trade secret misappropriation and other related claims brought in the Massachusetts State Court against Dicerna. In return, Dicerna will dismiss all counterclaims associated with Alnylam's trade secret misappropriation litigation, as well as all claims of anti-competitive practices brought by Dicerna against Alnylam in Massachusetts Federal Court. Dicerna will pay to Alnylam an upfront fee of $2M, plus 983,208 shares of Dicerna common stock. Dicerna will also pay to Alnylam an additional $13M over the next four years, the timing of which is dependent on revenue Dicerna receives pursuant to future GalXC technology-based partnerships. The settlement excludes any amounts received by Dicerna from its existing collaboration with Boehringer-Ingelheim. Neither company admits wrongdoing. Dicerna said it "remains focused on its core research and development activities, including its ongoing Phase 1 trial of DCR-PHXC, its lead compound for the treatment of all forms of primary hyperoxaluria, as well as the expected advancement of multiple other GalXC-based programs, including DCR-HBVS for hepatitis B, into clinical development on schedule. The company continues to anticipate having a total of three GalXC product candidates in the clinic by early next year."
PWOD

Hot Stocks

12:14 EDT Penns Woods Bancorp extends stock repurchase program - Penns Woods Bancorp announced that the company's board has authorized the extension of its repurchase plan. The repurchase plan is for an additional year ending April 30, 2019 and allows for the repurchase of up to 482,000 shares of which approximately 29% has been repurchased to date. Repurchases are authorized to be made by the company from time to time at the prevailing market prices on the open market, in block trades or in privately negotiated transactions as, in management's opinion, market conditions warrant.
BTC...

Hot Stocks

12:08 EDT The Intersection: Crypto and Wall Street This Week - As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly: 1. NY AG OPENS INQUIRY: On Tuesday, New York Attorney General Eric Schneiderman announced the launch of a "Virtual Markets Integrity Initiative," a "fact-finding inquiry into the policies and practices of platforms used by consumers to trade virtual or 'crypto' currencies like bitcoin and ether." As part of a broader effort to protect cryptocurrency investors and consumers, the Attorney General's office sent letters to thirteen virtual currency trading platforms requesting information on their operations, internal controls, and safeguards to protect customer assets. 2. AMAZON WINS BITCOIN-TRACKING PATENT: The U.S. Patent and Trademark Office has approved an Amazon Technologies' (AMZN) patent that can correlate different data streams, including bitcoin transactions, and sell the combined feed as a subscription to those who want to track the data, CNBC reported Friday. The filing described "a data stream that publishes or includes global bitcoin transactions, or any crypto currency transaction," and discussed how a law enforcement agency may want to track data on global bitcoin transactions that are linked to internet and physical shipping addresses. 3. COINBASE ACQUIRES EARN.COM, NAMES EXECS: In a Monday blog post, Earn.com said, "Earn.com is being acquired by Coinbase! The Earn.com product is going to get bigger and better as a consequence of this deal...With this acquisition, we allow users to also earn crypto by doing things they already know how to do-like replying to emails and filling out surveys...Open the Earn.com app in any country-and receive a personalized, targeted list of paid microtasks and emails just for you. Thanks to the blockchain, anywhere there's a phone, there's a job. We think that's an exciting vision and we're going to work hard on achieving that at Coinbase!" Following the announcement, Coinbase named Earn's co-founder and chief executive officer Balaji Srinivasan as the company's first chief technology officer and on Wednesday, the company announced it had hired Alesia Haas, who previously chief financial officer of Oz Management, as CFO. 4. BARCLAYS GAUGING CLIENT INTEREST IN CRYPTO: Barclays (BCS) has been gauging client interest in the bank starting a cryptocurrency trading desk, possibly joining Goldman Sachs (GS) in developing a new business on Wall Street, Bloomberg reported Monday. The bank, which currently has no concrete plans to begin trading digital currencies, has done a preliminary assessment of demand and feasibility. 5. SEC SUBPOENAS RIOT BLOCKCHAIN: Riot Blockchain (RIOT) received a subpoena from The Securities and Exchange Commission requesting "certain information," according to a Tuesday regulatory filing. Riot said it "intends to fully cooperate with the SEC request." The company has notified its insurance carrier but cautions that there can be no assurance that the costs of compliance with the subpoena or any related matters will be eligible for insurance coverage. Riot Blockchain added, "The company believes that many companies engaged in blockchain and cryptocurrency businesses have received subpoenas from the SEC which presents an additional industry risk. The existence of an investigation of the company specifically and the industry generally could have a materially adverse effect on the company, its business or operations, and the industry as a whole." In addition, chairman and CEO John O'Rourke said, "We continue to focus on the expansion of our cryptocurrency mining operations and the active investigation of launching a cryptocurrency exchange in the United States. We see a strong integration opportunity of supply and demand between our mining operation and a potential exchange." CRYPTO STOCK PLAYS: Cryptocurrency revenues have been pointed to as reasons to be bullish on Advanced Micro Devices (AMD) and Nvidia (NVDA) in select research. Overstock (OSTK), DPW Holdings (DPW), Long Blockchain (LBCC), Kodak (KODK), Seven Stars Cloud Group (SSC), Riot Blockchain, Longfin (LFIN), Pareteum (TEUM) and Social Reality (SRAX) are other stocks that have been touted, or promoted themselves, as a way to play the crypto theme PRICE ACTION: As of time of writing, bitcoin rose roughly 4.3% this week to $8,476 in U.S. dollars according to CoinDesk. WANT BITCOIN NEWS ALERTS?: To receive alerts on stories relating to bitcoin and other cryptocurrencies, Fly subscribers can enter "Bitcoin" into the "Add symbols" box of their portfolios.
SHPG TKPYY

Hot Stocks

12:06 EDT Shire spikes up 1.6% after commenting on latest Takeda proposal
SHPG TKPYY

Hot Stocks

12:04 EDT Shire 'considering position' on latest proposal from Takeda - Shire (SHPG) noted the announcement made by Takeda (TKPYY) and confirmed it has received a fourth proposal on April 20 regarding a possible offer for the company. The fourth proposal comprises GBP 26 per share in new Takeda shares, to be listed in Japan and in the U.S. through an ADR listing, and GBP 21 per share in cash, representing a potential value of GBP 47 per share and approximately GBP 44B for the total issued and to be issued share capital of the company. Based on Takeda's current market capitalisation, Shire shareholders would own approximately 49% of the enlarged Takeda. The board of Shire is considering its position with respect to the fourth proposal and will issue a further announcement in due course. This announcement was made without the consent of Takeda.
CMG TPR

Hot Stocks

12:01 EDT Chipotle names Marissa Andrada as Chief Human Resources Officer - Chipotle Mexican Grill (CMG) announced that it has hired Marissa Andrada as its chief human resources officer. Andrada will begin on April 23 and will report to Brian Niccol, the company's chief executive officer. Andrada comes to Chipotle from Kate Spade & Company (TPR), where she served as senior vice president of human resources and chief human resources officer.
SAGE...

Hot Stocks

12:01 EDT Sage Therapeutics slumps as Biogen deal may dampen M&A hopes - Weakness in shares of Sage Therapeutics (SAGE) may be related to news that Biogen (BIIB) and Ionis Pharmaceuticals (IONS) have expanded their strategic collaboration through a new ten-year collaboration agreement, which may be read by some market participants as lowering the odds for M&A action related to Sage. Under the terms of the collaboration, Biogen will pay Ionis $1B in cash, which will include $625M to purchase 11,501,153 shares of Ionis common stock at an approximately 25% cash premium, and a $375M upfront payment. On April 24, 2017, Sage announced the appointment of Michael Cloonan as Chief Business Officer. Cloonan had come to Sage from Biogen, where he worked for 14 years. On the date of that announcement, Adam Feuerstein of STAT tweeted, "$SAGE expands exec team, including former $BIIB - er Michael Cloonan as new Chief Business Officer. Stand down on $SAGE takeout for now." More recently, on April 10, 2018, shares of Sage has spiked higher in afternoon trading amid rumors of the company canceling from a planned presentation. A spokesperson for Sage Therapeutics told The Fly the company "cancelled participation in the JPMorgan meeting due to some travel logistics issues." In March, Canaccord analyst Sumant Kulkarni had assumed Sage Therapeutics with a Buy rating, citing among other things "a high scarcity value in its robust/ripening CNS platforms." In midday trading, Sage shares are down $17.90, or 10.5%, to $151.77.
AVXS

Hot Stocks

11:57 EDT Adage reports 6.04% stake in AveXis - Adage Capital Partners reports a 6.04% stake in AveXis, which represents 2.225M shares.
CMCSA...

Hot Stocks

11:11 EDT Comcast, Charter announce mobile operating platform partnership - Comcast (CMCSA, CMCSK) and Charter (CHTR) announced that the two companies have formed a 50/50 operating platform partnership focused on the development and design of backend systems that support Comcast's Xfinity Mobile and Charter's Spectrum Mobile service. The new partnership is the result of the continuing collaboration between Comcast and Charter in the mobile space, as each company continues to develop their respective mobile brands, products, and services. Through the agreement, Charter and Comcast will work together to cost-effectively develop an efficient and scalable software platform, and related backend systems, which will power each company's mobile-related customer sales and support platforms, device logistics and warehousing, and billing. The operating platform developed by the partnership will serve as the systems interface for current and any future MVNO partners. The partnership will leverage elements of the operating platform that Comcast initially developed for Xfinity Mobile, which Charter has modified for its upcoming mobile product and service platform launch. Charter will initially fund the joint venture to reflect certain development costs that Comcast has already made in mobile-related platforms and technology. Thereafter, the partners will equally fund the operations of the partnership. Each company will continue to maintain their own relationships with device manufacturers. In addition, all customer-facing activities including customer service, marketing, sales, pricing and packaging will be handled individually by Charter and Comcast. The partnership will be governed by a four-person board of directors, with two directors representing each of Comcast and Charter. The partnership will be based in Philadelphia and will utilize Comcast employees to support the development of the platform on behalf of both companies.
INCY LLY

Hot Stocks

11:09 EDT Before the Move: Nomura worries about Incyte's RA drug after 'ominous' docs - Shares of Incyte (INCY) are in focus after the Food and Drug Administration released briefing documents on baricitinib, a rheumatoid arthritis treatment developed by Incyte and submitted for review by Eli Lilly (LLY), ahead of an advisory panel vote on Monday. FDA DOCUMENTS: On Thursday, the FDA released its advisory committee meeting briefing documents for baricitinib. Baricitinib, proposed trade name Olumiant, is an oral small molecule inhibitor of the Janus associated kinases being proposed for the treatment of adult patients with moderately to severely active RA who have had an inadequate response or are intolerant to methotrexate. The drug was developed by Incyte and licensed to Eli Lilly, who holds the New Drug application. According to the documents, "Phase 2 trials evaluated doses of baricitinib ranging from 1 mg to 10 mg. While there was some evidence that all doses of baricitinib were efficacious compared to placebo with respect to ACR20 response in patients with RA, Lilly chose to carry forward two doses of baricitinib into the phase 3 clinical program...There was a general agreement by the FDA review team that the data submitted demonstrated the efficacy for baricitinib in RA at doses of 2 mg and 4 mg once daily for signs and symptoms assessed by ACR response, as well as for physical function assessed by HAQ-DI response. In trials that included both doses of baricitinib, the data were not consistent in showing a benefit of 4 mg over the 2 mg dose... One of the challenges of the baricitinib clinical program is assessment of safety. As with other RA programs, there was a limited placebo control period and patients could escape and/or cross over to baricitinib 4 mg. When most of the safety data are from baricitinib treatment groups and there are limited control group data, interpretation of imbalance in adverse reactions between treatment groups is problematic...The FDA reviews identified a safety profile of baricitinib consistent with that of a potent immunosuppressant with major safety risks of serious and some fatal infections, including opportunistic infections and tuberculosis, malignancy, laboratory abnormalities of increase in platelet counts, decrease in neutrophil counts, and increases in lipid parameters, and serum creatine phosphokinase. Many of these adverse reactions appeared to be dose-dependent...Because the majority of the safety data are with the higher dose of baricitinib, the identified safety issues raised concern regarding the 4 mg dose of baricitinib. The limited safety database with the lower dose complicated the benefit/risk assessment of the 2 mg dose of bariticitinib...Lilly submitted a response to the CR action on December 4...In the re-submission, Lilly proposed a different dosing strategy for baricitinib....The proposed dosing strategy in the resubmission is more complicated and deviates from labeling for other non-biologic DMARD RA products. This is also problematic, given that the clinical development program was not designed to support the proposed dosing strategy." ANALYST VIEW: Nomura Instinet analyst Christopher Marai says yesterday's briefing documents indicate that approval is unlikely. However, he does expect new clinical data on the lower dose of the drug to better assess the risk/benefit of that dose. The analyst calls the FDA document "ominous" but keeps a Buy rating on Incyte with a $102 price target. Conversely, William Blair analyst Y. Katherine Xu said there is a high chance baricitinib can obtain a positive outcome at the meeting and she remains confident in the drug's demonstrated efficacy. Xu does believe that safety remains a key question for baricitinib and the remainder of the second-generation JAK inhibitor class. The analyst has a Market Perform rating on Incyte. Meanwhile, UBS analyst Carter Gould said while the risk/benefit summary assessment was more positive and supportive of the 4mg dose approval, the documents did include negative commentary from a division head questioning approvability of the 2mg or 4mg dose. However, he believes the panel could be more "accommodating" than the division head on the epidemiological data to put the thrombotic risk with the 4mg dose in context. Additionally, Raymond James analyst Reni Benjamin said the documents "typically read negatively" as additional data in the resubmission of the NDA did not appear to significantly change the FDA's view on efficacy and safety. However, the analyst said the U.S. approval of baricitinib will likely have little impact on Incyte and he maintains an Outperform on the stock while continuing to recommend shares to long-term, risk-tolerant investors. PRICE ACTION: Incyte fell 0.8% to $68.47 in morning trading. From its closing level of $70.07 on April 18, the stock is down about 2% since the release of the briefing documents ahead of Monday's review.
DM

Hot Stocks

10:41 EDT Dominion Midstream increases distribution by 5% to 33.4c per share - The board of directors of Dominion Energy Midstream, the general partner of Dominion Energy Midstream Partners, has declared a first-quarter 2018 cash distribution of 33.4c per common and subordinated unit - an increase of 5% above the fourth-quarter 2017 distribution - which corresponds to an annualized distribution rate of about $1.34 per such unit. Distributions are payable on May 15 to unitholders of record at the close of business May 4.
GOGO

Hot Stocks

10:32 EDT Gogo names Jon Cobin Chief Strategy Officer - Jon Cobin will serve as Chief Strategy Officer and EVP Corporate Development. In this newly created role, Cobin will be responsible for leading Gogo's companywide business, strategic planning and corporate development efforts as Gogo seeks to leverage the CA and BA product portfolios to drive growth and shareholder value. Cobin joined Gogo in 2010 and has held various leadership positions in the CA division, most recently serving as executive VP and Chief Commercial Officer.
AWK

Hot Stocks

10:30 EDT American Water increases quarterly dividend 9.6% - American Water Works Company announced that its board increased its quarterly cash dividend payment to 45.5c per share from 41.5c per share, a 9.6% increase. The company has increased its dividend every year since its IPO in April 2008. The increased dividend will be payable on June 1 to all stockholders of record as of May 11.
CLF

Hot Stocks

10:22 EDT Cleveland-Cliffs says Q2 'looks really good' - On its Q1 earnings conference call, Cleveland-Cliffs said that as a result of the adoption of the new revenue recognition standard and the annual winter closure of the Soo Locks, revenues and net income will be relatively higher than historical levels for the last three quarters of the year. Says has "a lot to be excited about" this year. Says "never felt comfortable" with Australia-China trade situation. Says exiting APIO "quickly and efficiently." Says company "headed in the right direction." Says Q2 "looks really good."
LLY

Hot Stocks

10:19 EDT Eli Lilly to present data at AAN reinforcing commitment to migraine therapies - Eli Lilly said it will present Phase 3 data for galcanezumab and lasmiditan, two investigational treatments for migraine, at the American Academy of Neurology annual meeting taking place April 21-27 in Los Angeles. Lilly will highlight a new analysis from three Phase 3 studies -- EVOLVE-1, EVOLVE-2 and REGAIN -- evaluating galcanezumab in patients who previously failed two or more preventive therapies as part of the "Best in Headache" platform session on Tuesday, April 24. Lilly will also present data from two pivotal Phase 3 studies -- SAMURAI and SPARTAN -- side-by-side evaluating the safety and efficacy of lasmiditan for the acute treatment of migraine. Galcanezumab is a once-monthly, self-administered calcitonin gene-related peptide antibody currently under review by the U.S. FDA for the prevention of migraine in adults. Lasmiditan is an investigational, oral, first-in-class molecule that could represent the first significant innovation for the acute treatment of migraine in more than two decades.Galcanezumab and lasmiditan represent two of three investigational, non-opioid treatments in development as part of Lilly's overall pain portfolio. The portfolio also includes tanezumab, developed in partnership with Pfizer, for the treatment of osteoarthritis pain, chronic low back pain and cancer pain. "Like other recurrent and chronic pain conditions, migraine has a significant impact on a person's physical, social and economic well-being, yet there remains both a stigma and an unmet need for treatment options for this debilitating disease," said Robert Conley, M.D., Distinguished Lilly Scholar and Lilly global development leader for migraine therapeutics. "The data to be presented at AAN reflect Lilly's decades-long commitment to the development of new, innovative therapies in migraine, and reinforces the potential for galcanezumab and lasmiditan to address one of the biggest challenges in pain management today."
CIDM

Hot Stocks

10:12 EDT Cinedigm announces signing cooperation agreements with Chinese partners - Cinedigm announced six new Chinese entertainment partnerships that were formalized at a signing ceremony at the Beijing International Film Festival. Chris McGurk Cinedigm Chairman and CEO, said, "In addition to our already established relationships with Bison Capital and Starrise Media, these new partners will help provide significant, quality Chinese content and business understanding to help us jump start the flow of movies, TV and short-form programming into and out of China. We are particularly pleased to have announced our new Chinese content OTT channel for an American audience here and to have also signed an important Belt and Road cooperation agreement to participate with China in that key cultural exchange initiative."
MYO

Hot Stocks

09:59 EDT MIT work on advanced prosthetics to be highlighted on 60 Minutes - 60 Minutes teased an upcoming segment in which Scott Pelley will visit the Media Lab at the Massachusetts Institute of Technology. The report, which will be broadcast Sunday, April 22 at 7:00 p.m. ET/PT on CBS, will highlight "advanced prosthetics whose users are not only able to move their high-tech limbs, but feel them, too." Myomo, a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, was spun-off from labs at MIT and came public in 2017. Reference Link
GE

Hot Stocks

09:57 EDT GE off highs after JPMorgan's Tusa reiterates bear thesis on CNBC - Shares of General Electric moved off their highs after well-followed analyst Stephen Tusa reiterated his bearish thesis during an interview on CNBC. Tusa continues to believe consensus estimates are too high and that the stock is worth between $10 and $11. The analyst from JPMorgan noted that GE Power's results in Q1 were weaker than expected. Shares of General Electric are up 64c to $14.63 in early trading, off the highs seen on the open.
SHPG TKPYY

Hot Stocks

09:53 EDT Takeda raises takeover offer for Shire to GBP47.00 per share - Takeda Pharmaceutical (TKPYY) announced it is making an improved proposal to the Board of Shire plc (SHPG) to acquire the entire issued and to be issued share capital of Shire at a price equivalent to GBP47.00 per share, comprised of GBP21.00 in cash, to be paid in U.S. dollars, and GBP26.00 of new Takeda shares, which represents: an increase of approximately 7% to the original proposal of GBP 44.00 per share made on March 29, 2018; an increase of GBP3.25 and approximately 18% in cash per Shire share to the previous proposal made on April 12, 2018; and a premium of approximately 58% to Shire's closing share price of GBP29.81 on March 23, the last date prior to rumors of Takeda's possible interest in an offer for Shire. "Takeda believes that the Improved Proposal represents a highly compelling opportunity for Shire shareholders, which reflects a further increase in value and a material increase in the cash component of the consideration mix. On completion of the proposed acquisition, Shire shareholders would hold a very meaningful stake in a leading global biopharmaceutical company and benefit from the material synergies expected to be derived from the acquisition. Takeda will maintain its headquarters in Japan and primary listing on the Tokyo Stock Exchange and intends to put in place a NYSE listed ADR program at the point of completion to allow current Shire shareholders to continue to hold shares in the combined company...Takeda and its Board has remained disciplined with respect to the terms of the Improved Proposal and Takeda intends to maintain its well-established dividend policy and investment grade credit rating," the company stated.
SHPG TKPYY

Hot Stocks

09:51 EDT Takeda raises takeover offer for Shire to GBP47.00 per share
TRMD

Hot Stocks

09:50 EDT TORM PLC (Class A Stock) trading resumes
GE

Hot Stocks

09:50 EDT JPMorgan's Tusa still thinks GE shares are worth $10-$11 - JPMorgan analyst Steve Tusa is speaking on CNBC.
GE

Hot Stocks

09:48 EDT JPMorgan's Tusa still sees downside to General Electric estimates - JPMorgan analyst Steve Tusa is speaking on CNBC.
GE

Hot Stocks

09:48 EDT JPMorgan's Tusa says GE Power reported weaker than expected results - JPMorgan analyst Steve Tusa is speaking on CNBC.
GE

Hot Stocks

09:47 EDT JPMorgan's Tusa says GE quarter does not change bear thesis - JPMorgan analyst Steve Tusa is speaking on CNBC.
TRMD

Hot Stocks

09:45 EDT TORM PLC (Class A Stock) trading halted, volatility trading pause
HEB

Hot Stocks

09:45 EDT Hemispherx trading resumes
GE

Hot Stocks

09:32 EDT General Electric gains 7.4% to $15.02 in early trading following Q1 results
CVS

Hot Stocks

09:29 EDT CVS Pharmacy offering Hepatitis A vaccine to Kentuckians - CVS Pharmacy is encouraging unvaccinated Kentucky residents to receive the Hepatitis A vaccine following an increase in confirmed cases of the virus. According to the Kentucky Department for Public Health, more than 300 Hepatitis A cases have been confirmed across the state since 2017. Most recently, cases have been confirmed in Ashland, Berea and Louisville. All 79 CVS Pharmacy locations in Kentucky, including the nine CVS Pharmacy in Target locations, have the Hepatitis A vaccine available for people who have not yet been vaccinated. CVS Pharmacy stores located along the Kentucky border, such as those in Ironton, OH and Kenova, WV have the vaccine in stock as well, as do the three MinuteClinic locations in Kentucky.
CVS

Hot Stocks

09:28 EDT CVS Health Pharmacy offering Hepatitis A vaccine to Kentuckians - CVS Pharmacy is encouraging unvaccinated Kentucky residents to receive the Hepatitis A vaccine following an increase in confirmed cases of the virus. According to the Kentucky Department for Public Health, more than 300 Hepatitis A cases have been confirmed across the state since 2017. Most recently, cases have been confirmed in Ashland, Berea and Louisville. All 79 CVS Pharmacy locations in Kentucky, including the nine CVS Pharmacy in Target locations, have the Hepatitis A vaccine available for people who have not yet been vaccinated. CVS Pharmacy stores located along the Kentucky border, such as those in Ironton, OH and Kenova, WV have the vaccine in stock as well, as do the three MinuteClinic locations in Kentucky.
HEB

Hot Stocks

09:26 EDT Hemispherx trading halted, news pending
EAST

Hot Stocks

09:17 EDT Eastside Distilling announces RNDC to distribute Redneck Riviera in Kentucky - Eastside Distilling announced that Republic National Distributing Company, or RNDC, is distributing Redneck Riviera Whiskey in Kentucky. RNDC is the second largest spirits distributor in the US and Kentucky is the 15th state where Redneck Riviera Whiskey is in distribution since the initial product roll-out in February 2018. Redneck Riviera Whiskey is a joint collaboration between Eastside and John Rich, the multi-platinum country-music artist and one-half of the duo Big & Rich. In addition to Kentucky, Redneck Riviera Whiskey is currently distributed in Texas, California, Louisiana, Alabama, Georgia, Mississippi, Florida, North Carolina, North and South Dakota, Oregon, Tennessee, Oklahoma and Nebraska.
WFC

Hot Stocks

09:15 EDT Wells Fargo enters into consent orders with OCC, CFPB - Wells Fargo said it has entered into consent orders with the Office of the Comptroller of the Currency and Consumer Financial Protection Bureau that address matters pertaining to the company's compliance risk management program and issues regarding certain interest rate-lock extensions on home mortgages and collateral protection insurance placed on certain auto loans. The company has previously disclosed publicly the issues regarding interest rate-lock extensions and CPI. "For more than a year and a half, we have made progress on strengthening operational processes, internal controls, compliance and oversight, and delivering on our promise to review all of our practices and make things right for our customers," said Timothy J. Sloan, president and CEO of Wells Fargo. "While we have more work to do, these orders affirm that we share the same priorities with our regulators and that we are committed to working with them as we deliver our commitments with focus, accountability, and transparency. Our customers deserve only the best from Wells Fargo, and we are committed to delivering that." The orders, which are available in their entirety at the respective web sites for the OCC and CFPB, require the company to pay $1B in total civil money penalties. As a result, the company will adjust its first quarter 2018 preliminary financial results by an additional accrual of $800 million, which is not tax deductible. The accrual reduces reported first quarter 2018 net income by $800M, or 16c per diluted common share, to $4.7B, or 96c per diluted common share. Under the consent orders, Wells Fargo will also be required to submit, for review by its board, plans detailing its ongoing efforts to strengthen its compliance and risk management, and its approach to customer remediation efforts.
WFC

Hot Stocks

09:11 EDT CFPB announces settlement with Wells Fargo, assesses $1B fine - The Bureau of Consumer Financial Protection announced a settlement with Wells Fargo Bank, N.A. in a coordinated action with the Office of the Comptroller of the Currency. The Bureau found that Wells Fargo violated the Consumer Financial Protection Act in the way it administered a mandatory insurance program related to its auto loans. The Bureau also found that Wells Fargo violated the CFPA in how it charged certain borrowers for mortgage interest rate-lock extensions. Under the terms of the consent orders, Wells Fargo will remediate harmed consumers and undertake certain activities related to its risk management and compliance management. The Bureau assessed a $1B penalty against the bank and credited the $500M penalty collected by the OCC toward the satisfaction of its fine. Reference Link
GE

Hot Stocks

09:09 EDT General Electric CEO says starting to see 'green shoots' in Power
STT

Hot Stocks

09:09 EDT State Street says 'well positioned' to achieve FY18 objectives - Says approximately $1.6T of servicing assets remaining to be installed at quarter end will support revenue growth. Says making continued progress on Beacon. Says solid capital and leverage ratios to support business expansion. Comments from slides presentation for Q1 earnings conference call.
GE

Hot Stocks

09:08 EDT General Electric sees FY18 EPS closer to lower end of $1.00-$1.07 range
STI

Hot Stocks

09:08 EDT SunTrust to offer free identity protection after potential contact data theft - SunTrust Banks is now offering Identity Protection for all current and new consumer clients at no cost on an ongoing basis. Experian IDnotify will be provided to those who sign up for the service. The company became aware of potential theft by a former employee of information from some of its contact lists. Although the investigation is ongoing, SunTrust is proactively notifying approximately 1.5 million clients that certain information, such as name, address, phone number and certain account balances may have been exposed. The contact lists did not include personally identifying information, such as social security number, account number, PIN, User ID, password, or driver's license information. SunTrust is also working with outside experts and coordinating with law enforcement. The IDnotify product by Experian is being offered in addition to existing SunTrust security protocols.
WFC

Hot Stocks

09:07 EDT OCC says $1B fine assessed against Wells Fargo for 'unsound practices' - The Office of the Comptroller of the Currency assessed a $500M civil money penalty against Wells Fargo Bank, N.A., and ordered the bank to make restitution to customers harmed by its unsafe or unsound practices, and develop and implement an effective enterprise-wide compliance risk management program. The OCC's action was closely coordinated with an action by the Bureau of Consumer Financial Protection and made possible through the collaborative approach taken by the bureau. Separately, the bureau assessed a $1B penalty against the bank and credited the amount collected by the OCC toward the satisfaction of its fine, the OCC announced.
GE

Hot Stocks

09:06 EDT GE sees sale of value-based care solutions unit completed in Q3 - The sale of GE's healthcare digital value-based care solutions division to Veritas Capital is expected to close in Q3, GE said.
GE

Hot Stocks

09:05 EDT GE exploring options to sell Distributed Power business, WP's Long tweets - The Washington Post's Heather Long tweeted: "Just In: GE is trying to sell its entire Distributed Power division. A notice sent to employees this morning said GE 'has already seen strong interest' and a sale could come 'mid-2018'." The unit includes the Jenbacher and Waukesha product lines. Reference Link
BXG

Hot Stocks

09:05 EDT Bluegreen Vacations renews Quorom purchase facility - Bluegreen Vacations, along with Bluegreen/Big Cedar Vacations, a joint venture in which Bluegreen Vacations has a majority interest, announced the renewal of the non-recourse VOI notes receivable purchase facility with Quorum Federal Credit Union. Under this renewal, Quorum has agreed to purchase, on a revolving basis, eligible VOI notes receivable in an aggregate purchase price of up to $50M. As of April 6, $21.1M was outstanding under the Quorum Purchase Facility. The amendment to the Quorum Purchase Facility extended the purchase period from June 30 to June 30. As part of this amendment, Quorum agreed to an interest rate of 4.95% per annum on advances made through September 30, 2018. The interest rate on advances made after September 30, 2018 will be set at the time of funding based on rates mutually agreed upon by all parties. The amendment also reduced the loan purchase fee applicable to future advances from 0.50% to 0.25% and extended the maturity of the Quorum Purchase Facility from December 2030 to December 2032.
RILY BONT

Hot Stocks

09:04 EDT Great American Group, Tiger Capital to immediately liquidate all Bon-Ton Stores - Great American Group, a subsidiary of B. Riley Financial (RILY), and Tiger Capital Group, a provider of asset valuation, advisory and disposition services, announced that they have engaged with Bon-Ton Stores (BONT) to facilitate the orderly exit of the remaining 212 operating Bon-Ton locations across the United States. The store closing sales began today, April 20, 2018 and are expected to last until all merchandise has been liquidated. Shoppers can expect to find significant, storewide savings on Bon-ton's broad assortment of national and private brand fashion apparel and accessories for women, men and children, as well as cosmetics and home furnishings.
KR GS

Hot Stocks

09:04 EDT Kroger announces $1.2B accelerated share repurchase program - The Kroger Co. (KR) announced it has completed the sale of its convenience store business unit to EG Group for $2.15B. After tax proceeds total $1.7B. $1.2B of the proceeds will be used to fund an accelerated share repurchase program. Kroger entered into an ASR agreement with Goldman Sachs & Co. (GS), pursuant to which on April 24, 2018, Kroger will pay $1.2B to Goldman, who will make an initial delivery to Kroger of approximately 36.1M Kroger common shares. The total number of shares that Kroger ultimately will receive under the ASR will be based generally on the average of the daily volume-weighted average prices of shares traded during the term of the agreement, subject to a collar provision that will establish minimum and maximum numbers of shares to be repurchased. The $1.2B ASR is an additional repurchase authorization approved by Kroger's Board of Directors, which is incremental to the $1B share repurchase program announced on March 15, 2018. Kroger will use the balance of the after tax proceeds to lower its net total debt to adjusted EBITDA ratio.
GE...

Hot Stocks

09:00 EDT On The Fly: Pre-market Movers - HIGHER: Ionis Pharmaceuticals (IONS), up 8% after announcing a 10-year expansion to its strategic collaboration with Biogen (BIIB) to develop drug candidates for neurological diseases. Under the terms of the collaboration, Biogen will pay Ionis $1B in cash, which will include $625M to purchase 11,501,153 shares of Ionis common stock at an approximately 25% cash premium, and a $375M upfront payment... Pinnacle Foods (PF), up 7.6% after Jana Partners disclosed that it has acquired a 9.1% stake because it believes the shares are undervalued and the firm intends to have discussions with members of Pinnacle's board of directors and management team... Twitter (TWTR), up 3.4% after MKM Partners analyst Rob Sanderson upgraded the stock to Buy from Neutral. UP AFTER EARNINGS: General Electric (GE), up 6.5%... Limelight Networks (LLNW), up 11%. DOWN AFTER EARNINGS: Skechers (SKX), down 25%... Clearwater Paper (CLW), down 31%... Atlassian (TEAM), down 11.5%. ALSO LOWER: SunTrust (STI), down 3% after disclosing on the company's first quarter earnings call that the bank discovered that a former employee, while employed at SunTrust, may have attempted to print information on approximately 1.5 million clients and share this information with a criminal third-party.
SYF PYPL

Hot Stocks

09:00 EDT Synchrony sees FY18 NIM 15.75%-16.25% - Says continues to generate strong deposit growth. Says capital position remains strong. Says important objective is to extend the utility of cards. Says making strategic investments to ensure cardholders can easily use cards. Says digital sales penetration for retail card business is growing. Says continued to deliver growth across all sales platforms in Q1. Expects loyalty program expense to trend near 100%, with some quarterly fluctuation. Expects expenses to be largely driven by growth, including strategic investments and direct deposit program. Says sees FY18 NIM about 15.75%-16.25%, including the impact of the PayPal (PYPL) credit portfolio acquisition. Expects loan loss reserve builds in Q2 to be similar to Q1 in the $175M range. Says credit normalization continues to moderate. Expects FY18 efficiency ratio around 31%. Expects to grow deposits in line with receivables growth. Says continues to execute on capital plan announced in May. Expects to continue deploying capital through dividends and share buybacks. Expects core reserve builds to continue to moderate throughout the year which will help EPS growth. Comments taken from Q1 earnings conference call.
GE

Hot Stocks

08:57 EDT General Electric: Aviation market continues to be strong
ABCB

Hot Stocks

08:56 EDT Ameris Bancorp sees normalized ROTCE of 16%-18% for 2018 - Ameris Bancorp says efficiency ratio below 60% ahead of pending M&A deals that should drive additional operating leverage. Regarding M&A opportunities, the company notes, "current capital position gives us significantly more flexibility in driving consideration mix and metrics." Comments from Q4 earnings presentation slides.
SBLK

Hot Stocks

08:53 EDT Star Bulk acquires 16 vessels from Augustea Atlantic, York Capital Management - Star Bulk Carriers announced that it has agreed to acquire 16 vessels from entities affiliated with Augustea Atlantica and York Capital Management in an all-share transaction As consideration for the Vessel Acquisition, Star Bulk has agreed to issue approximately 10.5 million common shares to the sellers of the 16 vessels, equal to approximately 14.1% of Star Bulk's common shares after the closing of the Vessel Acquisition. Under the terms of the agreement with the sellers, the consideration will be determined based on the average vessel valuations by independent vessel appraisers and is subject to adjustments for cash, debt and capex on the closing date. As part of the transaction, the company will assume debt of $310M. The Vessel Acquisition, which is expected to be consummated in the second quarter of 2018, remains subject to the execution of definitive finance agreements and customary closing conditions. An entity affiliated with family members of our CEO, Mr. Petros Pappas, is a passive minority investor in 3 of the 16 acquired vessels. The technical management of the 16 vessels will remain with an entity affiliated with Augustea Atlantica SpA, while commercial management will be taken over by Star Bulk.
SLS

Hot Stocks

08:51 EDT Sellas Life Sciences appoints Gene Mack as CFO, Treasurer - Sellas Life Sciences Group announced the appointment of Gene Mack as CFO and Treasurer. Mack joins Sellas having served as a consulting chief financial officer for a number of private and publicly traded biotechnology and pharmaceutical companies. Interim CFO Aleksey Krylov will remain with SELLAS until July 15 in order to facilitate the transition.
MIDD

Hot Stocks

08:50 EDT Middleby acquires Josper S.A. - Middleby announced the acquisition of Josper S.A., a manufacturer of charcoal grill and oven cooking equipment for commercial foodservice and residential applications. Based in Spain, near Barcelona, Josper has approximately $20M in annual revenues.
STI

Hot Stocks

08:50 EDT SunTrust discloses attempt by former employee to steal data from 1.5M clients - SunTrust CEO William Rogers said on the company's first quarter earnings call that, in conjunction with law enforcement, the bank discovered that a former employee, while employed at SunTrust, may have attempted to print information on approximately 1.5 million clients and share this information with a criminal third-party. "We believe this information included names and account balances, but it did not include personally identifiable information, such as social security members, account numbers, pins, user ids, passwords or driver's license numbers. We and third parties have done forensic analysis on these accounts, and we've not identified significant fraudulent activity regarding the affected accounts. All that said, we're guided by our purpose of lighting the way to financial well-being and this applies to client information activity as well. So for this reason, we're going to offer a broad set of ongoing identity protection services to all of our clients free of charge, not just those potentially impacted. Given the increased performance and importance of information security and our client-first principle, I was convinced that this comprehensive and proactive approach was the right decision. There'll be modest costs for this and other investments in clients financial confidence, but we expect to be able to absorb those in our normal course of business. More broadly, I remain optimistic about our company's future both in 2018 and beyond," stated Rogers on the call. In pre-market trading as the call continues, SunTrust shares are down about 3% to $65.05.
USAT

Hot Stocks

08:49 EDT USA Technologies announces resignation of Chief Product Officer - USA Technologies disclosed last night that effective April 16, Mandeep Arora resigned as Chief Product Officer. Arora's resignation was not a result of any disagreement with the company, its management or directors on any matter relating to the operations, policies or practices of the company, USA Technologies said in a regulatory filing.
GE

Hot Stocks

08:46 EDT GE says overall market for new gas orders in 2018 trending to less than 30GW - In Power, says came into the year expecting overall market for new gas orders in 2018 to be 30-34GW, but now says this is trending to less than 30GW.
GE

Hot Stocks

08:44 EDT GE: Pressure in Power to be offset by better Aviation, Healthcare earnings
RDVT...

Hot Stocks

08:39 EDT Red Violet subsidiary partners with Berkshire Hathaway Home Service - Forewarn, a red violet company (RDVT), announced that Berkshire Hathaway (BRK.A, BRK.B) HomeServices Colorado Properties has secured Forewarn for all 100+ of its affiliated agents in an effort to promote proactive real estate agent safety. Available both online and through a mobile application, Forewarn analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity using just a phone number, searching for criminal histories, and validating information provided by potential clients such as financial and asset information. The Forewarn services purchased by BHHS Colorado Properties will be available at no cost to affiliated agents.
CHN

Hot Stocks

08:38 EDT The China Fund sareholder City of London responds to annual meeting postponement - The China Fund shareholders City of London Investment Management Company, which represents clients who are the beneficial owners of approximately 27.6% of the outstanding shares of common stock of The China Fund, issued a response to the announcement that the Board of Directors of China Fund has again postponed China Fund's 2018 annual meeting of stockholders, now to May 23. City of London states, among other things, that it believes "(...) the actions of the Board can only be viewed as further attempts to block China Fund's stockholders from exercising their fundamental right to vote and thereby replace the two incumbent Directors, including Joe Rogers, China Fund's Chairman who has served on the Board for 26 years, and terminate the investment manager. (...) The Board's ongoing posturing, multiple annual meeting postponements, entrenchment actions and never-ending litigation are extremely expensive and are a waste of China Fund assets. These costs are reducing China Fund's NAV, with costs increasing on a daily basis as a result of the Board's actions, and gradually will erode the share price of China Fund. (...) The latest postponement comes even after the federal court in New York found China Fund's claims challenging City of London's proxy materials to be without merit. The Board also announced a change to China Fund's Bylaws in an apparent attempt to retroactively permit the Board's meeting postponements under China Fund's governing documents. (...) We encourage all China Fund stockholders to vote their shares on the blue proxy card. (...)"
CHN

Hot Stocks

08:38 EDT The China Fund sareholder City of London responds to annual meeting postponement - The China Fund shareholders City of London Investment Management Company, which represents clients who are the beneficial owners of approximately 27.6% of the outstanding shares of common stock of The China Fund, issued a response to the announcement that the Board of Directors of China Fund has again postponed China Fund's 2018 annual meeting of stockholders, now to May 23. City of London states, among other things, that it believes "(...) the actions of the Board can only be viewed as further attempts to block China Fund's stockholders from exercising their fundamental right to vote and thereby replace the two incumbent Directors, including Joe Rogers, China Fund's Chairman who has served on the Board for 26 years, and terminate the investment manager. (...) The Board's ongoing posturing, multiple annual meeting postponements, entrenchment actions and never-ending litigation are extremely expensive and are a waste of China Fund assets. These costs are reducing China Fund's NAV, with costs increasing on a daily basis as a result of the Board's actions, and gradually will erode the share price of China Fund. (...) The latest postponement comes even after the federal court in New York found China Fund's claims challenging City of London's proxy materials to be without merit. The Board also announced a change to China Fund's Bylaws in an apparent attempt to retroactively permit the Board's meeting postponements under China Fund's governing documents. (...) We encourage all China Fund stockholders to vote their shares on the blue proxy card. (...)"
HON

Hot Stocks

08:35 EDT Honeywell says expects one or two acquisitions in next couple of quarters
RP

Hot Stocks

08:34 EDT RealPage to acquire ClickPay - RealPage announced its agreement to acquire ClickPay, an electronic payment platform servicing 2.3M units across the multifamily, HOA, condominium and co-op segments of real estate. ClickPay significantly expands RealPage's footprint into the HOA owner-occupied segment of real estate, broadens the company's presence in the New York metropolitan market and solidifies the integration of its front-end leasing platform into third-party property management systems. The acquisition adds nearly $1.0B to the company's total addressable market. The HOA market is estimated to contain over 16M units, and RealPage estimates that current and future solutions applicable to the market aggregate to a total opportunity of approximately $60 per unit per year. Including the HOA market, the holistic RealPage platform is expected to serve multiple segments of real estate, from rentals to owner occupied units, totaling over 62M units. Total current and future applicable solutions for those units represent nearly $205 per unit per year, for a total addressable market of over $12.7B. It also creates one of the largest payment processing platforms for real estate assets with over $55B of annual run-rate transaction volume.
GE

Hot Stocks

08:34 EDT General Electric: Cash 'front and center in every conversation'
GE

Hot Stocks

08:34 EDT General Electric: Power continues to be company's biggest challenge - Says Power will be "multi-year fix." Comments taken from the Q1 earnings conference call.
ABEO

Hot Stocks

08:33 EDT Abeona Therapeutics granted Orphan Drug Designation for ABO-202 in Europe - Abeona Therapeutics announced that the European Medicines Agency Committee for Orphan Medicinal Products has granted Orphan Drug Designation for Abeona's gene therapy program ABO-202 for the treatment of subjects with neuronal ceroid lipofuscinosis, also known as Batten Disease, a fatal lysosomal storage disease that primarily affects the nervous system in children. ABO-202 is an adeno-associated virus developed to introduce a functional copy of the CLN1 gene into cells in order to restore the enzyme activity that is needed to break down certain lipopigment proteins that are deficient in patients with CLN1 disease. ABO-202 is anticipated to enter clinical trials in 2018. ABO-202 has been granted Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration. Preclinical data from the program were recently presented at the WORLDSymposium held in San Diego and an update will be presented at the American Society for Gene and Cell Therapy later this year. Key findings reported included: The data demonstrate that a single intravenous, single intrathecal or combination therapy utilizing both administration routes of a self-complementary adeno-associated virus encoding the human CLN1 gene to CLN1 mice significantly increased their survival, improved behavior and reduced motor deficits. Higher doses further improved these observations, suggesting that methods increasing total CNS exposure may be beneficial and provided some survival and behavioral benefit to symptomatic mice. A combination approach delivering ABO-202 by both intravenous and intrathecal routes of administration further increased survival efficacy and improved potential treatment options for older animals with advanced disease manifestations.
TRIP

Hot Stocks

08:32 EDT TripAdvisor acquires Bokun, terms not disclosed - TripAdvisor announced it acquired Bokun, a leading provider of business management technology for the tours, attractions and experiences industry. With the acquisition, TripAdvisor expands its offering, now providing suppliers with technical solutions in addition to the sector's largest distribution channel. Bokun will remain based in Iceland, with immediate plans to expand the team. Terms of the acquisition will not be disclosed.
HON

Hot Stocks

08:24 EDT Honeywell says experienced more than 20% growth in China in Q1
CPG

Hot Stocks

08:22 EDT Crescent Point Energy holder Cation Capital says ISS supports agenda - Cation Capital, a private investment firm and shareholder of Crescent Point Energy, announced that Institutional Shareholder Services, has come out in support of Cation's call for change at Crescent Point. ISS recommends shareholders vote for Cation's board nominees, Dallas J. Howe and Herbert C. Pinder, and withold votes for Crescent Point directors Rene Amirault and Mike Jackson, as well as recommending that all Crescent Point shareholders use Cation's universal BLUE proxy or BLUE VIF to vote on ALL matters. In a further rebuke to the Crescent Point Board, ISS also recommends shareholders vote AGAINST the advisory vote on executive compensation, because of "high concern based on relative degree of pay-and-performance alignment measure, which concern is evident even when the Company's self-selected peer group is utilized."
DSX

Hot Stocks

08:19 EDT Diana Shipping enters time charter contract for m/v Arethusa with Glencore - Diana Shipping announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Glencore Agriculture, Rotterdam, for one of its Panamax dry bulk vessels, the m/v Arethusa. The gross charter rate is $12,600 per day, minus a 5% commission paid to third parties, for a period of minimum twelve months to maximum fifteen months. The charter is expected to commence on April 25, 2018. The m/v Arethusa is currently chartered, as previously announced, to Noble Resources International, Singapore, at a gross charter rate of $7,200 per day, minus a 5% commission paid to third parties.The "Arethusa" is a 73,593 dwt Panamax dry bulk vessel built in 2007. This employment is anticipated to generate approximately $4.54M of gross revenue for the minimum scheduled period of the time charter.
VAR

Hot Stocks

08:18 EDT Varian's Calypso transponder for lung granted FDA 510k clearance - Varian has received FDA 510(k) clearance for its Calypso Anchored Beacon transponder. Used with a Varian TrueBeam, Edge and Clinac C-series medical linear accelerators, the Calypso system and Anchored Beacon transponder detects even slight movements of a tumor and helps clinicians deliver lung stereotactic body radiotherapy more precisely.
ATOS

Hot Stocks

08:16 EDT Atossa Genetics announces 1-for-12 reverse stock split - Atossa Genetics announced a reverse split of its common stock at a ratio of 1-for-12, effective April 20, 2018. The reverse split was approved by the Company's stockholders at an annual meeting of the stockholders initially held on April 12, 2018 and reconvened on April 19, 2018. The Company's common stock will continue to trade on the NASDAQ Capital Market under the trading symbol "ATOS." As a result of the reverse split, each twelve pre-split shares of common stock outstanding will automatically combine into one new share of common stock without any action on the part of the holders, and the number of outstanding common shares will be reduced from approximately 31.8 million shares to approximately 2.65 million shares. The reverse split will also apply to common stock issuable upon the exercise of the Company's outstanding warrants and stock options.
CLF

Hot Stocks

08:14 EDT Cleveland-Cliffs makes changes to FY18 Cap-ex budget - The Toledo HBI Project spend expectation was reduced by $25M to $225M due to further development and refined timing of the project spending plan. The sustaining capital expectation of $85M was maintained and the Northshore Mine upgrade spend expectation of $50M was maintained.
CLF

Hot Stocks

08:12 EDT Cleveland-Cliffs increases FY18 Iron Ore revenue view to 20.5M long tons - Cliffs would realize USIO revenue rates in the range of $102 to $107 per long ton. This represents an increase from the prior calculation based on the substantial increase in hot-rolled coil steel prices, partially offset by lower iron ore prices. As a result of strong market demand for pellets in the Great Lakes, Cliffs has increased its full-year sales volume expectation by 500,000 long tons to 20.5M long tons. Its production volume expectation of 20M tons was maintained. Cliffs' full-year 2018 U.S. Iron Ore cash cost of goods sold and operating expense expectation was maintained at $58-$63 per long ton.
HON

Hot Stocks

08:08 EDT Honeywell says 'aggressively' pursuing acquisitions - Says does not anticipate "mega deals." Says deals will likely be in the $3B or less range.
DAL

Hot Stocks

08:03 EDT Delta Air Lines appoints Michael Huerta as new board member - Delta Air Lines' board of directors appointed Michael Huerta as its newest member. Huerta recently completed a five-year term as Administrator of the U.S. Federal Aviation Administration.
PLG

Hot Stocks

08:02 EDT Platinum Group receives final government approval for Maseve mine sale - Platinum Group Metals reports that government approval has been received for Royal Bafokeng Platinum Limited to acquire 100% of the shares in Maseve Investments 11 Ltd., the holding company of the Maseve Mine, and all shareholder loans owed by Maseve, for an aggregate consideration in cash and RBPlat common shares, valued on September 6, 2017 at approximately $16M. The South African Department of Mineral Resources has granted consent in terms of section 11 of the Mineral and Petroleum Resources Development Act to transfer the entire issued share capital in Maseve held by the Company and one minority shareholder to RBPlat. Maseve is the holder of the mining right underlying the Maseve Mine. With the grant of section 11 approval all conditions precedent to the completion of the sale of Maseve to RBPlat have now been met.
VXRT

Hot Stocks

08:01 EDT Vaxart announces $5M Inavir revenue milestone - Vaxart announced hat it received notification from Daiichi Sankyo Co., Ltd, that sales of Inavir, a single dose product licensed in Japan to prevent or treat influenza infection, exceeded Y20B in the fiscal year 2017, triggering a $5M milestone payment to Vaxart. The payment is expected in the second quarter of 2018 and is in accordance with the terms of the 2009 Commercialization Agreement between Daiichi Sankyo and Biota Pharmaceuticals, a company recently acquired by Vaxart.
HON

Hot Stocks

07:53 EDT Honeywell says exposure to tariffs 'relatively minimal' - Says actively implementing mitigation programs. Says guidance reflects potential impact of tariffs.
HON

Hot Stocks

07:45 EDT Honeywell says majority of tailwinds from Tax reform will occur in 2H18 - Sees FY18 effective tax rate approximately 22%-23%.
HON

Hot Stocks

07:43 EDT Honeywell says 'preference' is to deploy capital for M&A - Says in the absence of any M&A opportunities, will continue to focus on dividend and share buybacks.
HON

Hot Stocks

07:39 EDT Honeywell says seeing 'significant demand' for Android-based products - Expects that demand to be reflected in Q2 results.
HON

Hot Stocks

07:36 EDT Honeywell expects FY18 to be 'a very strong year' - Says expects more than $4B of cash repatriated in FY18. Comments from Q1 earnings conference call.
XNET

Hot Stocks

07:34 EDT Xunlei launches blockchain platform ThunderChain - Xunlei announced that it has launched ThunderChain, a high-performance blockchain platform, which can concurrently conduct millions of transactions per second. Based on Xunlei's proprietary homogeneous multichain framework, ThunderChain is designed to realize confirmation and interaction among homogeneous chains and enable multiple transactions to be executed on different chains in parallel. An optimized practical byzantine fault tolerance is adopted by ThunderChain as its consensus model which results in low latency and makes it possible to generate one block per second. PBFT, as a consistency algorithm, is also able to avoid soft fork. ThunderChain supports smart contracts written in solidity language and is compatible with Ethereum Virtual Machine, making it easy to migrate applications from other blockchain platforms. The company also announced to partner with InfoQ, a global leading community for tech developers, to host a Blockchain Applications Global Challenge. The goal is to develop blockchain applications and cultivate talents to help overcome complex challenges facing multiple industries, including logistics, healthcare, education and the public sectors. Participants are invited to develop decentralized applications on ThunderChain. The winning teams will receive cash prizes and have opportunities to receive angel investments in addition to opportunities to learn from the global blockchain experts. The Challenge is open for registration on April 20, 2018 and the deadline for project submissions is June 15, 2018.
HON

Hot Stocks

07:29 EDT Honeywell says 'actively managing impact of enacted tariffs'
HON

Hot Stocks

07:19 EDT Honeywell says preparation for spins continues, timing on track
HON

Hot Stocks

07:19 EDT Honeywell sees FY18 free cash flow $5.3B-$5.9B, up 7%-20% - Sees FY18 segment margin 19.3%-19.6%, up 30-60 bps.
STT

Hot Stocks

07:14 EDT State Street CEO says Q1 servicing commitments of $1.3T at record level - In announcing financial results, Joseph Hooley, State Street's chairman and CEO, said, "First-quarter 2018 results reflect strong growth in both fee revenue and net interest income. Servicing fees increased 10% from 1Q17, reflecting strength in equity markets and continued strong business momentum." Hooley added, "We continue to execute on State Street Beacon, enhancing the client experience by providing new solutions and insights, while driving efficiencies across the organization. As a result of our multi-year investment in technology, we have been able to win new mandates and expand existing relationships as demonstrated by the record level of new servicing commitments of $1.3 trillion in 1Q18."
STT

Hot Stocks

07:10 EDT State Street reports Q1 fee revenue $2.36B vs. 2.2B last year - The estimated Basel III standardized common equity tier 1 ratio for Q1 was 10.8% and estimated tier 1 leverage ratio was 6.9%.
SLB

Hot Stocks

07:09 EDT Schlumberger sees FY18 CapEx approx. $2B, similar to 2017, 2016 - Says US tax reform significantly changes US corporate income tax laws by, among other things, reducing the US corporate income tax rate to 21% starting in 2018 and creating a territorial tax system with a one-time mandatory tax on previously deferred foreign earnings of US subsidiaries. Absent the impact of US tax reform, the Company's ETR would likely increase by approximately 2 to 3 percentage points in 2018 as compared to fourth quarter 2017 ETR. However, the impact of US tax reform for 2018 is expected to largely offset this increase. As a result, Schlumberger expects the full-year 2018 ETR to approximate its Q4 2017 ETR before charges and credits.
SLB

Hot Stocks

07:08 EDT Schlumberger CEO Kibsgaard: Oil market 'is in balance' - Schlumberger Chairman and CEO Paal Kibsgaard commented, "Looking at the global oil market, the absence of global stock builds in the first quarter, supported by the OPEC- and Russia-led production cuts, confirm that the oil market is in balance. More importantly, after three consecutive years of dramatic underinvestment in global E&P spending, the worldwide production base has started to show the anticipated signs of weakness with noticeable year-over-year production declines appearing in several countries such as Angola, Norway, Mexico, Malaysia, China, and Indonesia. With Libya and Nigeria producing at near-full capacity, Venezuelan production in free fall, the potential of new sanctions against Iran, and rising geopolitical risks, the only major sources of short-term supply growth to address global production decline and strong worldwide demand are Saudi Arabia, Kuwait, the UAE, Russia, and the US shale oil industry. However, production challenges in US shale are emerging that are linked to infill drilling well-to-well interference, the potential lower production of step-out drilling from Tier 1 acreage, and significant infrastructure constraints. It is, therefore, becoming increasingly likely that the industry will face growing supply challenges over the coming year and a significant increase in global E&P investment will be required to minimize the impending deficit. We remain optimistic about the outlook for sustainable activity growth in our global business over the course of 2018 and into 2019. This is driven by higher customer activity and our ability to capture a major share of the emerging opportunities as performance-based contracts and integrated projects continue to gain traction as the preferred business models for many of our customers. Recent contract awards, which include the major lump-sum turnkey contracts in Saudi Arabia, additional wins elsewhere in the Middle East and Latin America, and new projects in the US Delaware Basin, are examples of this market trend. Our increased R&E focus in recent years on systems innovation and design is now enabling us to create additional value for both our customers and Schlumberger on these projects. This is achieved by integrating a new generation of purpose-built hardware and software with our deep domain expertise and the latest advances in digital technologies. Therefore, we are excited about the outlook for Schlumberger. We are ready and primed to deliver superior growth, financial returns, and free cash flow in the coming years by building on the broadest technology offering and expertise in the industry, our unmatched scale and operational efficiency, strong capital discipline, and a clear desire to provide industry-leading cash returns to our shareholders."
TRU

Hot Stocks

07:06 EDT GTCR confirms sale of Callcredit to TransUnion for GBP1B in cash - GTCR announced that it has signed a definitive agreement to sell Callcredit Information Group to TransUnion for GBP1B in cash consideration. The transaction is anticipated to close late in the second quarter or early in the third quarter pending regulatory approval.
VLRX

Hot Stocks

07:04 EDT Valeritas, Glooko partner for V-Go SIM - Valeritas Holdings announced it has entered into an agreement with Glooko. With this agreement, Valeritas will provide future V-Go SIM users with Glooko's cloud-based mobile and web diabetes data management platform to help track and analyze their diabetes care plan. Users can also share their data with their providers. V-Go SIM is a new, durable accessory that will snap onto Valeritas' flagship product, V-Go Wearable Insulin Delivery device, and is designed to provide one-way Bluetooth communication from the V-Go SIM to a patient's smart device. The V-Go SIM's onboard electronics will provide information regarding V-Go's use and wirelessly transmit such data via a V-Go SIM application on a mobile device. This app will have the functionality to store, display, and share recorded on-board insulin delivery data and the status of V-Go to the patient and his or her healthcare provider. By partnering with Glooko, the patient can use the Glooko application not only to upload and analyze insulin usage data, but to also upload blood glucose levels and daily patient carbohydrate, food, and medication intake. Combining this patient diabetes management data within the Glooko platform will give V-Go SIM users and their healthcare providers a more robust view of how each patient is managing his or her diabetes and will enable better informed regimen and behavior modifications. The V-Go SIM is investigational and not expected to be available for full commercial use in the U.S. until 1H19. Valeritas and Glooko will be working collaboratively to ensure a seamless experience for V-Go SIM users and healthcare providers using the new platform when it becomes available.
ABCB

Hot Stocks

07:03 EDT Ameris Bancorp reports Q1 net interest margin 3.92% - Including accretion income and reflecting this decrease, the company's net interest margin declined to 3.92% compared with 3.94% in the fourth quarter of 2017.
LCI TEVA

Hot Stocks

06:59 EDT Lannett names Maureen Cavanaugh to CCOO position - Lannett (LCI) announced the appointment of Maureen Cavanaugh to the newly created position, senior VP and CCOO, effective May 7. In this role, Cavanaugh will be responsible for sales and marketing, research and development and regulatory affairs. For the last 11 years, Cavanaugh worked for Teva Pharmaceuticals (TEVA) USA, most recently as senior VP, CCO, North America Generics, where she had oversight responsibility for leading trade sales, new product planning and portfolio management teams, as well as the long range planning and strategy development processes for the company's U.S. generics business. In conjunction with the appointment of Cavanaugh, the company re-aligned management responsibilities to further strengthen operational execution and empowerment. John Kozlowski has been named chief of staff and strategy officer and John Abt,, has been promoted to VP and CQOO. Kozlowski, who joined Lannett in 2009 and most recently served as COO, will be responsible for business development, strategy, project management and human resources. Abt, who has served for the last three years as VP of quality and previously served as VPof U.S. operations for Teva, will now have overall responsibility for production, supply chain and quality.
BHGE

Hot Stocks

06:55 EDT Baker Hughes CEO says 'We made strong progress in the quarter' - "We made strong progress in the quarter, securing several key commercial wins, executing on our synergy targets and delivering for our customers. I am pleased with our performance on our priorities of growing share, improving margins and generating cash," said Lorenzo Simonelli, BHGE chairman and CEO. In the first quarter, we delivered $5.2 billion in orders and $5.4 billion in revenue. As expected, we saw growth in our shorter-cycle businesses and declines in our longer-cycle businesses versus the previous year. Adjusted operating income* in the quarter was $228 million. Free cash flow* was $226 million. Market fundamentals remain supportive, as crude oil prices are relatively rangebound, providing stability to customers as they evaluate projects. The gas market continues to grow, and strong LNG demand supports the view that new capacity will be required in the early to mid-part of the next decade. BHGE is uniquely positioned across the oil and gas value chain, and well placed to benefit from the long-term industry trends."
ZTCOY

Hot Stocks

06:53 EDT ZTE Corp. calls 'most severe penalty' by U.S. an unfair punishment - ZTE said in a statement, "The Bureau of Industry and Security (hereinafter referred to as "BIS") activated the Suspended Denial Order on 16 April 2018, on the ground that ZTE did not timely reduce bonus of and issue letters of reprimand to certain employees involved in past violation of export control and made false statements in correspondence with the U.S. Government. ZTE has been working diligently on Export Control Compliance program and has invested tremendous resources in export compliance and has made significant progress since 2016. It is unacceptable that BIS insists on unfairly imposing the most severe penalty on ZTE even before the completion of investigation of facts, ignoring the continuous diligent work of ZTE and the progress we have made on export compliance and disregarding the fact that (1) ZTE self-identified the issues in the correspondence and self-reported by ZTE immediately; (2) the Company has taken measures against the employees who might have been responsible for this incident; (3) corrective measures has been taken immediately; and (4) a prestigious U.S. law firm has been engaged to conduct independent investigation. The Denial Order will not only severely impact the survival and development of ZTE, but will also cause damages to all partners of ZTE including a large number of U.S. companies. In any case, ZTE will not give up its efforts to resolve the issue through communication, and we are also determined, if necessary, to take judicial measures to protect the legal rights and interests of our Company, our employees and our shareholders, and to fulfill obligations and take responsibilities to our global customers, end-users, partners and suppliers. As a global company originating in China, ZTE will unite all of its employees as one with full confidence to work together taking best efforts to facilitate a final resolution."Reference Link
TRU

Hot Stocks

06:51 EDT TransUnion to acquire Callcredit for $1.4B - TransUnion announced its agreement to purchase Callcredit Information Group, the second largest consumer credit bureau in the U.K., headquartered in Leeds. Founded in 2000, Callcredit is a U.K.-based information solutions company that, like TransUnion, provides data, analytics and technology solutions to help businesses and consumers make informed decisions. TransUnion agreed to acquire Callcredit for GBP1B, which is approximately $1.4B at current exchange rate. The acquisition is anticipated to close late in Q2 or early in Q3 pending regulatory approval.
HGT

Hot Stocks

06:50 EDT Hugoton Royalty Trust declares no April cash disttribution - Simmons Bank, as trustee of the Hugoton Royalty Trust, declared there would not be a cash distribution to the holders of its units of beneficial interest for April due to the excess cost positions on all three of the Trust's conveyances of net profits interests. Underlying gas sales volumes attributable to the current month were primarily produced in February.
BHGE

Hot Stocks

06:48 EDT Baker Hughes reports backlog of $22.2B at Q1-end - Backlog in the first quarter ended at $22.2B, an increase of $1.2B or 6% from the fourth quarter of 2017. The increase was primarily driven by the impact from adopting the new revenue recognition accounting standard (ASC Topic 606, Revenue from Contracts with Customers). Equipment backlog was $5.4B, up 1%, sequentially. Services backlog was $16.8B, up $1.1B, or 7%, sequentially.
BHGE

Hot Stocks

06:45 EDT Baker Hughes reports Q1 orders of $5.2B - Down 8% sequentially and up 9% year-over-year on a combined business basis.
SYF

Hot Stocks

06:38 EDT Synchrony CEO says 'We started the year with solid results' - "We started the year with solid results as we continued to drive organic growth, while also winning exciting new partnerships. Furthermore, we closed several key renewals during the quarter and made investments to help augment our capabilities. Innovative value propositions, compelling promotional offers, and robust data, analytics and digital capabilities, remain a hallmark of our business, and continue to drive value for our partners and cardholders," said Margaret Keane, President and CEO of Synchrony Financial. "Returning capital to shareholders remains a key priority, and we are pleased to continue to return significant capital to shareholders through our dividend and share repurchase program, while also deploying capital through organic growth and program acquisitions."
GE

Hot Stocks

06:38 EDT GE CEO: On track to exceed cost reduction goal of $2B in 2018
HON

Hot Stocks

06:37 EDT Honeywell CEO: Q1 results driven by 'exceptional' sales, operational performance - "Honeywell had a very strong start to 2018, with first-quarter results that were driven by exceptional sales and operational performance. Organic sales grew 5%, driven by strong demand for original equipment for commercial aviation; U.S. defense; continued sales and orders growth in the warehouse automation business, Intelligrated; and short-cycle demand in process automation. Segment margin expanded by 40 basis points as a result of our Commercial Excellence efforts and from the Honeywell Operating System, including material productivity and volume leverage. EPS, excluding separation costs, were $1.95, up 14% year-over-year, exceeding the high end of our guidance range," said Darius Adamczyk, President and CEO of Honeywell. "Our balance sheet remains strong, and we continue to aggressively deploy capital. In the first quarter, we repurchased nearly $950M in Honeywell shares. As a result of our strong first-quarter performance, the healthy demand environment, and our continued confidence in our ability to execute, we are raising our full-year organic sales guidance to a new range of 3%-5% and our EPS guidance to a new range of $7.85-$8.05. We are also raising our free cash flow guidance by $0.1B after a strong Q1," Adamczyk continued. "We are making great progress in transforming Honeywell into a software-industrial leader. In the first quarter, we had significant new Connected product launches and commercial wins across our portfolio. The preparations to spin-off our Transportation Systems and Homes businesses are well underway, and we expect those to be complete by the end of the year. This is an exciting time to be a customer, shareowner, or employee of Honeywell, and I am confident in our ability to continue to outperform," Adamczyk concluded.
GE

Hot Stocks

06:35 EDT GE says plans to end 2018 with $15B+ of cash
SYF

Hot Stocks

06:35 EDT Synchrony reports Common Equity Tier 1 ratio under Basel III 16.8%
GE

Hot Stocks

06:35 EDT General Electric reports Q1 GE Capital revenue $2.17B, Aviation revenue $7.11B - Reports Q1 Oil and Gas revenue $5.39B, Health Care revenue $4.7B, Power revenue $7.22B, Renewable Energy revenue $1.65B, Transportation revenue $872M.
BIIB IONS

Hot Stocks

06:34 EDT Biogen, Ionis Pharmaceuticals expand drug development collaboration - Biogen (BIIB) and Ionis Pharmaceuticals (IONS) announced they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogen's expertise in neuroscience research and drug development and Ionis' leadership in RNA targeted therapies with the goal of developing a broad pipeline of investigational therapies. It builds upon a productive collaboration that produced SPINRAZA, the first and only approved treatment for patients with spinal muscular atrophy. Under the terms of the collaboration, Biogen will pay Ionis $1B in cash, which will include $625M to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, at an approximately 25% cash premium, and a $375M upfront payment. Biogen will have the option to license therapies arising out of this collaboration and will be responsible for their development and commercialization. In addition, Biogen may pay milestone payments, license fees and royalties on net sales. The companies plan to advance programs for a broad range of neurological diseases for which few treatment options exist today. Disease areas include dementia, neuromuscular diseases, movement disorders, ophthalmology, diseases of the inner ear, and neuropsychiatry. Biogen will have the first choice of neurology targets on which to exclusively collaborate with Ionis. In this collaboration, Ionis will be responsible for the identification of antisense drug candidates based on selected targets, while Biogen will be responsible for and pay for non-clinical studies, clinical development, manufacturing, and commercialization. Biogen and Ionis expect the deal to close in the second quarter of 2018.
GE

Hot Stocks

06:34 EDT GE CEO: No change to framework for 2018
GE

Hot Stocks

06:33 EDT GE CEO: Making progress on $20B of dispositions planned for 2018, 2019
GE

Hot Stocks

06:33 EDT General Electric CEO: Working to resolve legacy matters in discontinued ops
GE

Hot Stocks

06:32 EDT General Electric reaffirms FY18 guidance
SYF

Hot Stocks

06:32 EDT Synchrony reports Q1 net interest margin 16.05% - Return on assets was 2.7% and return on equity was 18.2%. Efficiency ratio was 30.9%.
SWK

Hot Stocks

06:12 EDT Stanley Black & Decker executed equity derivative deal to lock buyback pricing - During Q1, Stanley Black & Decker entered into a capped call transaction that provides the right to purchase 3.2M shares through March 2021. The company said this transaction supports its long-term strategy to return approximately 50% of free cash flow to shareholders via dividends and opportunistic share repurchases.
SWK

Hot Stocks

06:08 EDT Stanley Black & Decker CEO say Q1 organic growth up 4% - Stanley Black & Decker's President and CEO, James Loree, commented, "We had a strong start to 2018, with high-single digit EPS expansion in the face of significant commodity headwinds. We also reported healthy, above-market organic growth of 4%, backed by 6% organic growth from Tools & Storage as well as Industrial outperforming our expectation. The organic growth outlook remains robust as we execute a series of opportunities including Lenox and Irwin revenue synergies, FlexVolt, emerging markets and the rollout of the Craftsman brand, all while the organization remains focused on generating new core and breakthrough innovations. In addition to organic growth, we continue to focus on strategic capital allocation actions. The Nelson Fastener Systems acquisition was completed in early April. We continue to see a strong acquisition pipeline and are exploring multiple opportunities to create significant value."
MAT

Hot Stocks

06:08 EDT Ancestry names Margo Georgiadis as CEO - Ancestry announced that its Board of Directors has appointed Margo Georgiadis as CEO and member of the Board of Directors. Georgiadis will join the company on May 10, 2018. Most recently Georgiadis served as CEO of Mattel and prior to that as President, Americas, at Google Inc. Georgiadis will succeed Howard Hochhauser, who has served as interim CEO since October 2017 while the Board conducted a comprehensive six-month search for a permanent CEO. Hochhauser will return to his role as Ancestry's CFO and COO.
CLNE

Hot Stocks

06:07 EDT Clean Energy to build three CNG stations in Ontario for Union Energy Solutions - Clean Energy Fuels has been awarded a contract to construct three compressed natural gas fueling stations in Ontario, Canada for Union Energy Solutions, an unregulated affiliate of Union Gas - an Enbridge Company, a Canadian natural gas storage, transmission and distribution company. The three stations are expected to initially distribute an estimated 600,000 gasoline gallon equivalents per year.
RF

Hot Stocks

06:04 EDT Regions Financial sees gain of $200M from sale of Regions Insurance subsidiary - Subsequent to the end of the first quarter, Regions announced it had entered into a definitive agreement to sell its Regions Insurance subsidiary and affiliates. Subject to regulatory approval, the transaction is expected to close in the third quarter. In connection with management's decision to sell, the pending transaction meets the criteria for reporting as discontinued operations at March 31, 2018. Results of the entities being sold are reported in Regions' consolidated statements of income separately as discontinued operations for all periods presented. The company expects the transaction will result in an after-tax gain of approximately $200M, and will generate Common Equity Tier 1 of approximately $300M. Capital generated from this transaction at the time of closing is expected to be used to repurchase shares of common stock, subject to review and non-objection by the Federal Reserve as part of the 2018 Comprehensive Capital Analysis and Review.
CYD

Hot Stocks

06:03 EDT China Yuchai announces 800 buses exported to Saudi Arabia - China Yuchai, through its main operating subsidiary, Guangxi Yuchai Machinery Company Limited, or GYMCL, announced that 800 buses manufactured by Anhui Ankai Automobile and powered by GYMCL engines were recently exported to Saudi Arabia. GYMCL was the sole supplier for the heavy-duty engines to propel these 800 buses, 600 of which were installed with YC6MK engines, which are 6-cylinder turbocharged diesel engines with a displacement of 10.34 liters. The remaining 200 buses were equipped with GYMCL's heavy-duty diesel engine model YC6L, which is a compact, lightweight designed 6-cylinder turbocharged engine with a displacement of 8.42 liters.
BCS

Hot Stocks

06:03 EDT FCA, PRA conclude investigations into Barclays, CEO Jes Staley - As announced on April 10, 2017, the FCA and PRA have been conducting investigations into Jes Staley, Group Chief Executive Officer of Barclays, and Barclays Bank PLC in relation to an attempt by Mr Staley in 2016 to identify the author of an anonymous letter. The FCA and PRA have now concluded these investigations. In respect of Mr Staley, the FCA and PRA have recently issued confidential draft warning notices setting out their reasons for proposing enforcement actions. The FCA and PRA are alleging that Mr Staley's actions in relation to this matter represented a breach of Individual Conduct Rule 2 and each have proposed that he pay a financial penalty. The FCA and PRA are not alleging that he acted with a lack of integrity or that he lacks fitness and propriety to continue to perform his role as Group Chief Executive Officer. In accordance with the enforcement procedures of the FCA and PRA, Mr Staley now has a period during which he may review the draft warning notices and make representations to these authorities in relation to their content. Therefore, Barclays is not in a position to comment further on the draft warning notices, any discussions with the FCA and PRA or the timing of the final outcome of this matter. In light of the draft warning notices of the FCA and PRA, the Barclays Board continues to be satisfied with its conclusions as set out in the April 2017 Announcement. The Barclays Board continues to have unanimous confidence in Mr Staley and continues to recommend his re-election as a Director at the Barclays Annual General Meeting on 1 May 2018. As set out in the April 2017 Announcement, the Barclays Board will determine what adjustment to Mr Staley's compensation is appropriate once the FCA and PRA processes have concluded. In respect of Barclays Bank PLC, the FCA and PRA have concluded that they will not take enforcement action in respect of this matter. However, they have proposed that each of Barclays Bank PLC and Barclays Bank UK PLC will be subject to requirements to report to the FCA and PRA on certain aspects of their whistleblowing programmes. Separately, in May 2017, the Barclays Board voluntarily commissioned independent reviews of Barclays' whistleblowing policies, processes and controls, in line with which certain enhancements have subsequently been made. Barclays continues to provide information to, and cooperate with, authorities in the US with respect to this matter.
RF

Hot Stocks

06:02 EDT Regions Financial reports Q1 net interest margin 3.46%
QGEN

Hot Stocks

05:25 EDT Qiagen announces FDA approval of PartoSure - Qiagen announced the U.S. regulatory approval of PartoSure, which is a novel test for assessing the risk of spontaneous preterm birth in patients with symptoms of preterm labor. The pre-market approval of PartoSure by the FDA follows successful uptake of the rapid, accurate test in more than 35 countries across Europe, the Middle East, Asia and Latin America. U.S. commercialization of the PartoSure test is expected to begin in 2018.
NVS

Hot Stocks

05:24 EDT Novartis announces new analyses from Phase III EXPAND study of oral siponimod - Novartis today announced new analyses from the Phase III EXPAND study of oral, once-daily siponimod in patients with secondary progressive multiple sclerosis, or SPMS. In pre-specified statistical analyses, treatment with siponimod consistently reduced the risk of confirmed disability progression in SPMS patients, with and without relapses. In addition, new post-hoc analyses using more accurate methods to estimate the treatment effect on disability progression, now substantiate that the risk reduction with siponimod is largely disassociated from relapses. Siponimod also showed a significant benefit on cognitive processing speed, the key cognitive function impacted by MS, which frequently deteriorates in people with the disease. These results are being presented at the 70th American Academy of Neurology Annual Meeting, in Los Angeles, April 21-27, 2018. As previously reported for the overall study population, treatment with siponimod resulted in a statistically significant risk reduction in disability progression sustained for three- and six-months. The new EXPAND study analyses, using a more advanced model-based approach, show an estimated risk reduction for disability progression, sustained at three-months that ranged from 14%-20% compared to placebo for non-relapsing patients. For disability sustained at six-months, estimated risk reduction was even greater, spanning from 29%-33%. Other complementary statistical approaches assessing the effect of siponimod on disability progression disassociated from relapses showed consistent results.
CTRP

Hot Stocks

05:21 EDT Ctrip signs MOU with AccorHotels - Ctrip.com announced that it has entered into a memorandum of understanding regarding its partnership with world-leading travel & lifestyle group and digital innovator AccorHotels. The partnership will allow Ctrip's over 300 million registered users to access and enjoy personalized experiences from AccorHotels' global brands portfolio, ranging from internationally acclaimed luxury brands -including Raffles, Sofitel Legend, Fairmont, SO Sofitel, Sofitel, onefinestay, MGallery by Sofitel, Pullman, Swissotel and 25hours Hotels- as well as the popular midscale brands Novotel, Mercure, Mama Shelter and Adagio- to the much-prized economy brands including JO&JOE, ibis, ibis Styles, ibis budget and the regional brands Grand Mercure, The Sebel and hotelF1. AccorHotels operates 4,300 hotels and 10,000 private homes in 100 countries. The MOU is a milestone for both companies to embark on a deeper cooperation which will greatly enhance the growing Chinese travelers' journey globally. The partnership will focus on four strategic pillars, including highlighting AccorHotels accredited hotels more prominently, building a flagship store for AccorHotels, joint development of loyalty programs and cooperation on IT.
SJW...

Hot Stocks

05:19 EDT SJW Corp. remains committed to merger of equals with Connecticut Water - SJW Group (SJW) today issued the following statement regarding Connecticut Water Service's (CTWS) receipt and rejection of an unsolicited, non-binding indication of interest from Eversource Energy (ES) regarding a potential proposal to acquire Connecticut Water. "SJW Group and Connecticut Water previously announced on March 15, 2018, that they have entered into an agreement to combine through a merger of equals. Under the terms of the agreement, Connecticut Water shareholders will receive 1.1375 shares of SJW Group common stock for each share of Connecticut Water common stock they own, the equivalent of $63.70 per share, based on SJW Group's closing stock price on April 19, 2018. Connecticut Water's shareholders would benefit not only from an immediate 21% premium to the closing share price on March 14, 2018 - the day prior to the merger announcement - but, importantly, will retain future upside through a 40 percent ownership of the combined company. SJW Group is committed to the existing merger agreement with Connecticut Water, which remains on track to close by year-end 2018. The SJW Group Board continues to believe the merger of equals provides the shareholders of both companies with the best opportunity for value creation over the long term."